Patent US5141957A successfully refreshed from Google Patents.
US5141957A
Expired / Lapsed
US
⏱️ 0.0 years remaining
1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
Assignee: Eli Lilly and Co
•
Filing: 1990-11-05
•
Granted: 1992-08-25
•
Expires: 2010-11-05
Abstract
Abstract The present invention provides novel substituted anthraquinones having the formula <IMAGE> wherein R1 and R2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR3R4, Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR5, or CONR6R7; R3, R4, R5, R6, and R7 are independently H, lower alkyl or aryl useful for inhibiting protein kinase C and treating conditions related to, or affected by inhibition of protein kinase C, particularly cancer tumors, inflammatory disease, reperfusion injury, and cardiac dysfunctions related to reperfusion injury.
Inventors
- 👤 Jack B. Jiang
- 👤 Mary G. Johnson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 06:07
CPC Classifications
C; C07; C07C; C07C225/00; C07C225/24; C07C225/26; C07C225/32; C07C225/34; C07C225/36; A; A61; A61P; A61P29/00; A61P35/00; A61P43/00; A61P7/00; A61P7/02; A61P9/00
Claims Analysis
Total Claims: 46
Claim 1
Independent Claim
77 words
A substituted anthraquinone having the formula ##STR4## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 2
Dependent Claim
77 words
A substituted anthraquinone having the formula ##STR4## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 3
Dependent Claim
38 words
The substituted anthraquinone of claim 1 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 4
Dependent Claim
28 words
The substituted anthraquinone of claim 2 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 5
Dependent Claim
22 words
A pharmaceutical composition for inhibiting protein kinase C comprising a substituted anthraquinone of claim 1 and a pharmaceutically acceptable carrier or diluent.
Claim 6
Dependent Claim
22 words
A pharmaceutical composition for inhibiting protein kinase C comprising a substituted anthraquinone of claim 2 and a pharmaceutically acceptable carrier or diluent.
Claim 7
Dependent Claim
22 words
A pharmaceutical composition for inhibiting protein kinase C comprising a substituted anthraquinone of claim 3 and a pharmaceutically acceptable carrier or diluent.
Claim 8
Independent Claim
95 words
A method of inhibiting protein kinase C which comprises contacting protein kinase C with an inhibitory amount of a substituted anthraquinone having the formula ##STR5## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 9
Independent Claim
95 words
A method of inhibiting protein kinase C which comprises contacting protein kinase C with an inhibitory amount of a substituted anthraquinone having the formula ##STR5## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 10
Dependent Claim
37 words
The method of claim 7 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 11
Dependent Claim
27 words
The method of claim 8 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 12
Independent Claim
99 words
A method of inhibiting an oxidative burst in neutrophils which comprises contacting a neutrophil with a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR6## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl,; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 13
Independent Claim
99 words
A method of inhibiting an oxidative burst in neutrophils which comprises contacting a neutrophil with a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR6## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl,; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 14
Dependent Claim
37 words
The method of claim 10 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 15
Dependent Claim
27 words
The method of claim 11 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 16
Dependent Claim
29 words
A method of inhibiting an oxidative burst in neutrophils which comprises contacting a neutrophil with an amount of a compound of claim 1 effective to inhibit said oxidative burst.
Claim 17
Dependent Claim
29 words
A method of inhibiting an oxidative burst in neutrophils which comprises contacting a neutrophil with an amount of a compound of claim 2 effective to inhibit said oxidative burst.
Claim 18
Dependent Claim
29 words
A method of inhibiting an oxidative burst in neutrophils which comprises contacting a neutrophil with an amount of a compound of claim 3 effective to inhibit said oxidative burst.
Claim 19
Independent Claim
97 words
A method for treating inflammation which comprises administering to a mammal suffering from inflammation a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR7## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 20
Independent Claim
97 words
A method for treating inflammation which comprises administering to a mammal suffering from inflammation a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR7## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 21
Dependent Claim
37 words
The method of claim 16 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 22
Dependent Claim
27 words
The method of claim 17 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 23
Dependent Claim
26 words
A method for treating inflammation which comprises administering to a mammal suffering from inflammation an amount of a compound of claim 1 effective to inhibit inflammation.
Claim 24
Dependent Claim
26 words
A method for treating inflammation which comprises administering to a mammal suffering from inflammation an amount of a compound of claim 2 effective to inhibit inflammation.
Claim 25
Dependent Claim
26 words
A method for treating inflammation which comprises administering to a mammal suffering from inflammation an amount of a compound of claim 3 effective to inhibit inflammation.
Claim 26
Independent Claim
101 words
A method for inhibiting growth of mammalian tumor cells which comprises contacting a mammalian tumor cell with a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR8## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 27
Independent Claim
101 words
A method for inhibiting growth of mammalian tumor cells which comprises contacting a mammalian tumor cell with a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR8## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 28
Dependent Claim
37 words
The method of claim 22 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 29
Dependent Claim
27 words
The method of claim 23 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 30
Dependent Claim
34 words
A method for inhibiting growth of mammalian tumor cells which comprises contacting a mammalian tumor cell with an amount of a compound of claim 1 effective to inhibit growth of said mammalian tumor cell.
Claim 31
Dependent Claim
34 words
A method for inhibiting growth of mammalian tumor cells which comprises contacting a mammalian tumor cell with an amount of a compound of claim 2 effective to inhibit growth of said mammalian tumor cell.
Claim 32
Dependent Claim
34 words
A method for inhibiting growth of mammalian tumor cells which comprises contacting a mammalian tumor cell with an amount of a compound of claim 3 effective to inhibit growth of said mammalian tumor cell.
Claim 33
Independent Claim
99 words
A method for treating mammalian tumors which comprises administering to a mammal having a tumor a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR9## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 34
Independent Claim
99 words
A method for treating mammalian tumors which comprises administering to a mammal having a tumor a protein kinase C inhibitory concentration of a substituted anthraquinone having the formula ##STR9## wherein R 1 and R 2 are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 35
Dependent Claim
37 words
The method of claim 28 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 36
Dependent Claim
27 words
The method of claim 29 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 37
Dependent Claim
30 words
A method for treating mammalian tumors which comprises administering to a mammal having a tumor an amount of a compound of claim 1 effective to inhibit growth of said tumor.
Claim 38
Dependent Claim
30 words
A method for treating mammalian tumors which comprises administering to a mammal having a tumor an amount of a compound of claim 2 effective to inhibit growth of said tumor.
Claim 39
Dependent Claim
30 words
A method for treating mammalian tumors which comprises administering to a mammal having a tumor an amount of a compound of claim 3 effective to inhibit growth of said tumor.
Claim 40
Independent Claim
94 words
A method of inhibiting keratinocyte proliferation comprising administering to a keratinocyte a protein kinase C inhibitory amount of a compound having the formula ##STR10## wherein R 1 and R 2 are independently, H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 41
Independent Claim
94 words
A method of inhibiting keratinocyte proliferation comprising administering to a keratinocyte a protein kinase C inhibitory amount of a compound having the formula ##STR10## wherein R 1 and R 2 are independently, H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR 3 R 4 , Cl, Br, I, F, alkyl, aryl alkoxy, aroxy, COOR 5 , or CONR 6 R 7 ; R 3 , R 4 , R 5 , R 6 , and R 7 are independently H, lower alkyl or aryl.
Claim 42
Dependent Claim
37 words
The method of claim 33 wherein R 1 and R 2 independently are H, lower alkyl, or arylalkyl; m and n are independently 1 or 2; and X is H, OH, Cl, Br, I, F, or alkoxy.
Claim 43
Dependent Claim
27 words
The method of claim 35 wherein R 1 and R 2 independently are H or arylalkyl; m and n are 1; and X is H or OH.
Claim 44
Dependent Claim
28 words
A method of inhibiting mammalian keratinocyte cell proliferation comprising administering to said keratinocyte an amount of a compound of claim 1 effective to inhibit proliferation of said keratinocyte.
Claim 45
Dependent Claim
28 words
A method of inhibiting mammalian keratinocyte cell proliferation comprising administering to said keratinocyte an amount of a compound of claim 2 effective to inhibit proliferation of said keratinocyte.
Claim 46
Dependent Claim
28 words
A method of inhibiting mammalian keratinocyte cell proliferation comprising administering to said keratinocyte an amount of a compound of claim 3 effective to inhibit proliferation of said keratinocyte.
References Cited (Backward Citations)
US1540733A
Cited
US2411148A
Cited
US3960751A
Cited
US4197249A
Cited
US4310666A
Cited
US4526989A
Cited
US4598155A
Cited
US4540788A
Cited
US4762648A
Cited
US4894451A
Cited
JPS6315853A
Cited
US4816450A
Cited
JPH0219818A
Cited
DE3827974A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-08-25 | 1996-02-24 | 1996-08-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-08-25 | 2000-02-24 | 2000-08-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-08-25 | 2004-02-24 | 2004-08-25 | $7700.00 | Window Closed / Lapsed |